Hemispherian AS, a pioneering biotech company developing next-generation therapeutics for aggressive cancers, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug ...

The Bureau of Customs (BOC), along with the Department of Health (DOH) and the Department of Agriculture (DA), unveiled ...